よむ、つかう、まなぶ。
「日本人の食事摂取基準（2025年版）」策定検討会報告書 (455 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
| 出典情報 | 「日本人の食事摂取基準（2025年版）」策定検討会報告書（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
Diabetes Care. 2003;26(2):302-307.
84) Guasch-Ferré M, Becerra-Tomás N, Ruiz-Canela M, et al. Total and subtypes of dietary fat intake and risk
of type 2 diabetes mellitus in the Prevención con Dieta Mediterránea (PREDIMED) study. Am J Clin Nutr.
2017;105(3):723-735.
85) van Dam RM, Willett WC, Rimm EB, et al. Dietary fat and meat intake in relation to risk of type 2 diabetes
in men. Diabetes Care. 2002;25(3):417-424.
86) Salmerón J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin
Nutr. 2001;73(6):1019-1026.
87) Tobias DK, Chen M, Manson JE, et al. Effect of low-fat diet interventions versus other diet interventions
on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol.
2015;3(12):968-979.
88) Hodge AM, English DR, O’Dea K, et al. Plasma phospholipid and dietary fatty acids as predictors of type
2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr. 2007;86(1):189-197.
89) Wang L, Folsom AR, Zheng ZJ, et al. Plasma fatty acid composition and incidence of diabetes in middleaged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003;78(1):91-98.
90) Harding AH, Day NE, Khaw KT, et al. Dietary fat and the risk of clinical type 2 diabetes: the European
prospective investigation of Cancer-Norfolk study. Am J Epidemiol. 2004;159(1):73-82.
91) Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on glycaemic control in
patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab.
2011;58(4):290-296.
92) Yaegashi A, Kimura T, Wakai K, et al. Associations of total fat and fatty acid intake with the risk of type 2
diabetes mellitus among Japanese adults: Analysis based on the JACC study. J Epidemiol. 2024;34(7):316323.
93) Wendeu-Foyet G, Bellicha A, Chajès V, et al. Different types of industry-produced and ruminant trans fatty
acid intake and risk of type 2 diabetes: Findings from the NutriNet-Santé prospective cohort. Diabetes Care.
2023;46(2):321-330.
94) Post RE, Mainous AG 3rd, King DE, et al. Dietary fiber for the treatment of type 2 diabetes mellitus: a metaanalysis. J Am Board Fam Med. 2012;25(1):16-23.
95) Jovanovski E, Khayyat R, Zurbau A, et al. Should viscous fiber supplements be considered in diabetes
control? Results from a systematic review and meta-analysis of randomized controlled trials. Diabetes Care.
2019;42(5):755-766.
96) Ojo O, Feng QQ, Ojo OO, et al. The role of dietary fibre in modulating gut microbiota dysbiosis in patients
with type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials. Nutrients.
2020;12(11):3239.
97) Ojo O, Wang X, Ojo OO, et al. The effect of prebiotics and oral anti-diabetic agents on gut microbiome in
patients with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled
trials. Nutrients. 2022;14(23):5139.
98) Xu B, Fu J, Qiao Y, et al. Higher intake of microbiota-accessible carbohydrates and improved
cardiometabolic risk factors: a meta-analysis and umbrella review of dietary management in patients with
type 2 diabetes. Am J Clin Nutr. 2021;113(6):1515-1530.
445
84) Guasch-Ferré M, Becerra-Tomás N, Ruiz-Canela M, et al. Total and subtypes of dietary fat intake and risk
of type 2 diabetes mellitus in the Prevención con Dieta Mediterránea (PREDIMED) study. Am J Clin Nutr.
2017;105(3):723-735.
85) van Dam RM, Willett WC, Rimm EB, et al. Dietary fat and meat intake in relation to risk of type 2 diabetes
in men. Diabetes Care. 2002;25(3):417-424.
86) Salmerón J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin
Nutr. 2001;73(6):1019-1026.
87) Tobias DK, Chen M, Manson JE, et al. Effect of low-fat diet interventions versus other diet interventions
on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol.
2015;3(12):968-979.
88) Hodge AM, English DR, O’Dea K, et al. Plasma phospholipid and dietary fatty acids as predictors of type
2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr. 2007;86(1):189-197.
89) Wang L, Folsom AR, Zheng ZJ, et al. Plasma fatty acid composition and incidence of diabetes in middleaged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003;78(1):91-98.
90) Harding AH, Day NE, Khaw KT, et al. Dietary fat and the risk of clinical type 2 diabetes: the European
prospective investigation of Cancer-Norfolk study. Am J Epidemiol. 2004;159(1):73-82.
91) Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on glycaemic control in
patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab.
2011;58(4):290-296.
92) Yaegashi A, Kimura T, Wakai K, et al. Associations of total fat and fatty acid intake with the risk of type 2
diabetes mellitus among Japanese adults: Analysis based on the JACC study. J Epidemiol. 2024;34(7):316323.
93) Wendeu-Foyet G, Bellicha A, Chajès V, et al. Different types of industry-produced and ruminant trans fatty
acid intake and risk of type 2 diabetes: Findings from the NutriNet-Santé prospective cohort. Diabetes Care.
2023;46(2):321-330.
94) Post RE, Mainous AG 3rd, King DE, et al. Dietary fiber for the treatment of type 2 diabetes mellitus: a metaanalysis. J Am Board Fam Med. 2012;25(1):16-23.
95) Jovanovski E, Khayyat R, Zurbau A, et al. Should viscous fiber supplements be considered in diabetes
control? Results from a systematic review and meta-analysis of randomized controlled trials. Diabetes Care.
2019;42(5):755-766.
96) Ojo O, Feng QQ, Ojo OO, et al. The role of dietary fibre in modulating gut microbiota dysbiosis in patients
with type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials. Nutrients.
2020;12(11):3239.
97) Ojo O, Wang X, Ojo OO, et al. The effect of prebiotics and oral anti-diabetic agents on gut microbiome in
patients with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled
trials. Nutrients. 2022;14(23):5139.
98) Xu B, Fu J, Qiao Y, et al. Higher intake of microbiota-accessible carbohydrates and improved
cardiometabolic risk factors: a meta-analysis and umbrella review of dietary management in patients with
type 2 diabetes. Am J Clin Nutr. 2021;113(6):1515-1530.
445